Related Experiment Video

Updated: Aug 6, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
09:43

Measurement of Heme Synthesis Levels in Mammalian Cells

Published on: July 9, 2015

Bilirubin toxicity to human erythrocytes: a review

Maria Alexandra Brito1, Rui F M Silva, Dora Brites

  • 1Centro de Patogénese Molecular- UBMBE, Faculdade de Farmácia, University of Lisbon, Av. das Forças Armadas, 1600-083 Lisbon, Portugal. abrito@ff.ul.pt

Clinica Chimica Acta; International Journal of Clinical Chemistry
|August 5, 2006
PubMed

Insights

Neonatal jaundice is common, but high unconjugated bilirubin (UCB) levels can harm newborns. Understanding UCB toxicity and risk factors is crucial for preventing kernicterus.

Area of Science:

  • Neonatal Medicine
  • Bilirubin Metabolism
  • Neurotoxicity

Background:

  • Neonatal jaundice affects nearly all newborns, typically resolving without issue.
  • Unconjugated hyperbilirubinemia poses neurotoxic risks, especially with risk factors like prematurity and acidosis.

Purpose of the Study:

  • To review data on unconjugated bilirubin (UCB) toxicity in neonates.
  • To explore risk factors contributing to kernicterus.
  • To enhance understanding of UCB pathophysiology for improved risk assessment.

Main Methods:

  • Review of existing data on UCB toxicity.
  • Analysis of risk factors for kernicterus.
  • Focus on mechanisms of UCB pathophysiology.

Main Results:

  • UCB toxicity affects neuronal and circulating cells.
  • Hemolysis caused by UCB can worsen neonatal jaundice.
  • Specific risk factors exacerbate neurotoxicity.

Conclusions:

  • Understanding UCB pathophysiology is essential for assessing neurotoxicity risk.
  • Identifying and managing risk factors can prevent kernicterus.
  • Further research into UCB mechanisms is needed for improved neonatal care.

More Related Videos

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies09:51

Human Liver Spheroids from Peripheral Blood for Liver Disease Studies

Published on: January 27, 2023

Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model10:40

Visualization and Analysis of Blood Flow and Oxygen Consumption in Hepatic Microcirculation: Application to an Acute Hepatitis Model

Published on: August 4, 2012

Related Concept Videos

Jaundice01:25

Jaundice

Jaundice, or icterus, is the yellow discoloration of the skin, sclerae, and mucous membranes. It happens when plasma bilirubin levels rise above 2.5-3 mg/dL, leading to bilirubin deposition in tissue.Bilirubin is a byproduct of hemoglobin degradation. In macrophages, hemoglobin breaks down into globin and heme. Globin is converted into amino acids, while heme is turned into biliverdin by heme oxygenase, which is then reduced to unconjugated bilirubin by biliverdin reductase.Unconjugated...
Lifecycle of Erythrocytes01:22

Lifecycle of Erythrocytes

Erythrocytes, also known as red blood cells, constantly move through blood capillaries. As a result, they damage their plasma membrane due to the continuous friction. Typically, after 100 to 120 days, erythrocytes become rigid and fragile as they wear out. As they pass through small vessels in the spleen and liver, they can get trapped and break apart into fragments.
The resident phagocytic macrophages deal with these damaged cells by engulfing them and separating their globin and heme groups.
Disorders of Erythrocytes01:27

Disorders of Erythrocytes

Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test01:22

Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test

In clinical practice, the direct measurement of hepatic blood flow to evaluate liver function presents significant challenges due to the intricate and specialized nature of the necessary techniques. Consequently, healthcare professionals often rely on empirical estimates derived from thorough patient examinations and liver function tests to gauge liver health. Among the tools at their disposal, the Child–Pugh and MELD scoring systems stand out for their ability to categorize and assess the...
Erythropoiesis01:14

Erythropoiesis

Red blood cells  (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia, and...
Drug toxicity: Idiosyncratic Reactions01:16

Drug toxicity: Idiosyncratic Reactions

Idiosyncratic drug reactions represent abnormal chemical responses that vary significantly among individuals, ranging from extreme sensitivity to low doses to insensitivity to high doses. These reactions often occur due to the drug's covalent binding with serum proteins, forming a foreign hapten that triggers an immunotoxicological response. The variability in drug reactions has a strong pharmacogenetic foundation, with genetic differences crucial in how individuals metabolize drugs. For...